47
Views
174
CrossRef citations to date
0
Altmetric
Original Article

The effect of reduced glomerular filtration rate on plasma total homocysteine concentration

, , &
Pages 41-46 | Received 06 Apr 1995, Accepted 14 Sep 1995, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

P. García-Alfaro, I. Rodriguez & F. R. Pérez-López. (2022) Plasma homocysteine levels and handgrip strength in postmenopausal women. Climacteric 25:5, pages 504-509.
Read now
Patrick Steven Tucker, Vincent James Dalbo, Thin Han & Michael Ian Kingsley. (2013) Clinical and research markers of oxidative stress in chronic kidney disease. Biomarkers 18:2, pages 103-115.
Read now
Sion K Roy, Albert Cespedes, Dong Li, Tae-Young Choi & Matthew J Budoff. (2011) Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium. Vascular Health and Risk Management 7, pages 719-724.
Read now
Sanja Simić-Ogrizović, Dragana Radivojević, Milan Radovic, Višnja Ležaic, Dusan Mirković, Dusan Babić & Ljubica Dukanović. (2006) Factors Associated with Hyperhomocysteinemia After Renal Transplantation. Renal Failure 28:1, pages 57-62.
Read now
S. Raeder, S. Landaas, K. Laake, T. Lyberg & K. Engedal. (2006) Homocysteine measurements in geriatric patients. Scandinavian Journal of Clinical and Laboratory Investigation 66:4, pages 309-316.
Read now
Robert W. Powers, Michael S. Dunbar, Hannele M. Laivuori, Gail F. Harger, David L. Lykins & James M. Roberts. (2005) Maternal Plasma Homocysteine Concentrations Are Not Increased in Twin Pregnancies. Hypertension in Pregnancy 24:1, pages 49-58.
Read now
Jutta Dierkes, Sabine Westphal & Claus Luley. (2004) The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. Expert Opinion on Drug Safety 3:2, pages 101-111.
Read now
S. E. NILSSON, P.‐E. EVRIN, N. TRYDING, S. BERG, G. MCCLEARN & B. JOHANSSON. (2003) Biochemical values in persons older than 82 years of age: report from a population‐based study of twins. Scandinavian Journal of Clinical and Laboratory Investigation 63:1, pages 1-14.
Read now
Coen DA Stehouwer & Coen van Guldener. (2001) Homocysteine-lowering treatment: an overview. Expert Opinion on Pharmacotherapy 2:9, pages 1449-1460.
Read now
Z.K. Shihabi, M.E. Hinsdale & P.E. Lantz. (1998) Serum and Tissue Homocysteine Analysis by HPLC. Journal of Liquid Chromatography & Related Technologies 21:17, pages 2715-2723.
Read now

Articles from other publishers (164)

Tsuyoshi Ohishi, Tomotada Fujita, Tatsuya Nishida, Kazuhiro Hagiwara, Reina Murai & Yukihiro Matsuyama. (2022) Effect of denosumab on renal function in women with osteoporosis evaluated using cystatin C. Osteoporosis and Sarcopenia 8:2, pages 68-74.
Crossref
Wenyan Zhao, Faliang Gao, Laidi Lv & Xi Chen. (2022) The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. Journal of Hypertension 40:2, pages 254-263.
Crossref
Molud Ghanbari, Amir Hossein Miladipour, Sayyed Mohammad Hossein Ghaderian, Zahra Fazeli, Shirin Rajabi & Masoumeh Rajabibazl. (2022) Association between CRP polymorphisms and susceptibility to the diabetic nephropathy; A case-control study. Meta Gene 31, pages 101009.
Crossref
Nicola A. Gillies, Bernhard Franzke, Barbara Wessner, Barbara Schober-Halper, Marlene Hofmann, Stefan Oesen, Anela Tosevska, Eva-Maria Strasser, Nicole C. Roy, Amber M. Milan, David Cameron-Smith & Karl-Heinz Wagner. (2021) Nutritional supplementation alters associations between one-carbon metabolites and cardiometabolic risk profiles in older adults: a secondary analysis of the Vienna Active Ageing Study. European Journal of Nutrition 61:1, pages 169-182.
Crossref
Charles Chazot, Alison L. Steiber & Joel D. Kopple. 2022. Nutritional Management of Renal Disease. Nutritional Management of Renal Disease 413 465 .
Rajesh K. Kesharwani, Govind Prasad Dubey, D. Jain, V. N. Mishra, Rajesh Dubey & Rudra P. Ojha. 2022. Homocysteine Metabolism in Health and Disease. Homocysteine Metabolism in Health and Disease 115 134 .
Prashant Kumar, Sunil Kumar Verma, Sweta Rai, P. Shakti Prakash & Dheeraj Chitara. 2022. Homocysteine Metabolism in Health and Disease. Homocysteine Metabolism in Health and Disease 257 276 .
Peng-Tzu Liu & Jong-Dar Chen. (2021) Synergistic association of hyperuricemia and hyperhomocysteinemia with chronic kidney disease in middle-aged adults and the elderly population. Medicine 100:37, pages e27202.
Crossref
Po-Ju Chen, Yueh-Chien Lu, Pei-Ming Wang, Chih-Fang Huang & Song-Seng Loke. (2021) Factors associated with hyperhomocysteinemia in relatively healthy Taiwanese adults. Medicine 100:3, pages e23829.
Crossref
Sopak Supakul, Floris Chabrun, Steve Genebrier, Maximilien N’Guyen, Guillaume Valarche, Arthur Derieppe, Adeline Villoteau, Valentin Lacombe & Geoffrey Urbanski. (2020) Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency. Journal of Clinical Medicine 9:8, pages 2335.
Crossref
Tsuyoshi Ohishi, Tomotada Fujita, Daisuke Suzuki, Tatsuya Nishida, Mitsuru Asukai & Yukihiro Matsuyama. (2018) Serum homocysteine levels are affected by renal function during a 3-year period of minodronate therapy in female osteoporotic patients. Journal of Bone and Mineral Metabolism 37:2, pages 319-326.
Crossref
Feijie Wang, Liang Sun, Qi Sun, Liming Liang, Xianfu Gao, Rongxia Li, An Pan, Huaixing Li, Yueyi Deng, Frank B. Hu, Jiarui Wu, Rong Zeng & Xu Lin. (2018) Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate. Clinical Journal of the American Society of Nephrology 13:4, pages 560-568.
Crossref
Constantine E Kosmas, Delia Silverio, Christiana Tsomidou, Maria D Salcedo, Peter D Montan & Eliscer Guzman. (2018) The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease. Clinical Medicine Insights: Endocrinology and Diabetes 11, pages 117955141879225.
Crossref
Ioanna Markaki, Stefanos Klironomos, Konstantinos Kostulas & Christina Sjostrand. (2017) Elevated plasma homocysteine upon ischemic stroke is associated with increased long-term mortality in women. PLOS ONE 12:8, pages e0183571.
Crossref
Kyoko Maesato, Takayasu Ohtake, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Hidekazu Moriya, Sumi Hidaka & Shuzo Kobayashi. (2017) Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study. PLOS ONE 12:4, pages e0175102.
Crossref
Chunyan Zhang, Xiaobin Wang, Mingli He, Xianhui Qin, Genfu Tang, Xin Xu, Yu Wang, Yong Huo, Yefeng Cai, Jia Fu, Gang Zhao, Qiang Dong, Xiping Xu, Binyan Wang & Fan Fan Hou. (2015) Proteinuria Is an Independent Risk Factor for First Incident Stroke in Adults Under Treatment for Hypertension in China. Journal of the American Heart Association 4:12.
Crossref
Takashi NAGAI, Keizo SAKAMOTO, Sadaaki TSUTSUI, Takuma KURODA, Takaaki KANAZAWA & Katsunori INAGAKI. (2015) The Relationship Between Serum Homocysteine Levels and Vertebral Fractures. The Showa University Journal of Medical Sciences 27:2, pages 103-110.
Crossref
Erkan Demir, Volkan Izol, I. Atilla Aridogan, Saime Paydas, Zuhtu Tansug & Ugur Erken. (2014) Immediate and long-term high levels of plasma homocysteine after extracorporeal shock wave lithotripsy in patients with renal stone disease. Clinical and Experimental Nephrology 18:4, pages 623-625.
Crossref
Galit Weinstein & Sudha Seshadri. (2014) Circulating biomarkers that predict incident dementia. Alzheimer's Research & Therapy 6:1, pages 6.
Crossref
Bridgette M.H. Haynes, Christine M. Pfeiffer, Maya R. Sternberg & Rosemary L. Schleicher. (2013) Selected Physiologic Variables Are Weakly to Moderately Associated with 29 Biomarkers of Diet and Nutrition, NHANES 2003–2006. The Journal of Nutrition 143:6, pages 1001S-1010S.
Crossref
Charles Chazot & Joel D. Kopple. 2013. Nutritional Management of Renal Disease. Nutritional Management of Renal Disease 351 382 .
David C. Wheeler, Richard Haynes, Martin J. Landray & Colin Baigent. 2012. Brenner and Rector's The Kidney. Brenner and Rector's The Kidney 2059 2080 .
Carla Cristina Silva de Almeida, Daiane Cristina Guerra, Maria Terezinha I. Vannucchi, Tufik J.M. Geleilete, Helio Vannucchi & Paula Garcia Chiarello. (2011) What Is the Meaning of Homocysteine in Patients on Dialysis?. Journal of Renal Nutrition 21:5, pages 394-400.
Crossref
W. SingerI.O. YungR. WollmannT. KellyB.M. Keegan. (2011) A middle-aged woman with nausea, weight loss, and orthostatic hypotension. Neurology 77:5, pages 489-495.
Crossref
Kari Anne R. Tobin, Kirsten B. Holven, Kjetil Retterstøl, Ellen Strøm, Leiv Ose, Pål Aukrust & Marit S. Nenseter. (2009) Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins. British Journal of Nutrition 102:12, pages 1783-1789.
Crossref
Wolfgang Herrmann & Rima Obeid. 2009. Endogenous Toxins. Endogenous Toxins 787 839 .
K. Sakakura, N. Kubo, J. Ako, N. Fujiwara, H. Funayama, N. Ikeda, T. Nakamura, Y. Sugawara, T. Yasu, M. Kawakami & S.-i. Momomura. (2009) Determinants of Long-Term Mortality in Patients With Type B Acute Aortic Dissection. American Journal of Hypertension 22:4, pages 371-377.
Crossref
Jessica Kendrick & Michel B Chonchol. (2008) Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nature Clinical Practice Nephrology 4:12, pages 672-681.
Crossref
Kathleen PotterGraeme J. HankeyDaniel J. GreenJohn W. EikelboomLeonard F. Arnolda. (2008) Homocysteine or Renal Impairment. Arteriosclerosis, Thrombosis, and Vascular Biology 28:6, pages 1158-1164.
Crossref
Christine M Pfeiffer, John D Osterloh, Jocelyn Kennedy-Stephenson, Mary Frances Picciano, Elizabeth A Yetley, Jeanne I Rader & Clifford L Johnson. (2008) Trends in Circulating Concentrations of Total Homocysteine among US Adolescents and Adults: Findings from the 1991–1994 and 1999–2004 National Health and Nutrition Examination Surveys. Clinical Chemistry 54:5, pages 801-813.
Crossref
Bradley L. Urquhart & Andrew A. House. (2020) Assessing Plasma Total Homocysteine in Patients with End-Stage Renal Disease. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27:5, pages 476-488.
Crossref
C. Lewerin, S. Ljungman & H. Nilsson-Ehle. (2007) Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly. Journal of Internal Medicine 261:1, pages 65-73.
Crossref
F. Pizzolo, S. Friso, O. Olivieri, N. Martinelli, C. Bozzini, P. Guarini, E. Trabetti, G. Faccini, R. Corrocher & D. Girelli. (2006) Homocysteine, traditional risk factors and impaired renal function in coronary artery disease. European Journal of Clinical Investigation 36:10, pages 698-704.
Crossref
M Y Lee, J Myers, J Abella, V F Froelicher, I Perkash & B J Kiratli. (2005) Homocysteine and hypertension in persons with spinal cord injury. Spinal Cord 44:8, pages 474-479.
Crossref
M R Graham, F M Grace, W Boobier, D Hullin, A Kicman, D Cowan, B Davies & J S Baker. (2006) Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse. British Journal of Sports Medicine 40:7, pages 644-648.
Crossref
Carmine Zoccali & Jan T Kielstein. (2006) Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?. Current Opinion in Nephrology and Hypertension 15:3, pages 314-320.
Crossref
AMELIA R BERNASCONI, ANDRES LISTE, NOEMI DEL PINO, GUILLERMO J ROSA DIEZ & RICARDO M HEGUILEN. (2006) Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure. Nephrology 11:2, pages 137-141.
Crossref
Kathy Jabs, Mark J. Koury, William D. Dupont & Conrad Wagner. (2006) Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children. Metabolism 55:2, pages 252-257.
Crossref
Fabiana Baggio Nerbass, Sérgio Antônio Draibe, Simone Flach Feiten, Paula Garcia Chiarello, Hélio Vannucchi & Lilian Cuppari. (2006) Homocysteine and Its Determinants in Nondialyzed Chronic Kidney Disease Patients. Journal of the American Dietetic Association 106:2, pages 267-270.
Crossref
R. Castro, I. Rivera, H. J. Blom, C. Jakobs & I. Tavares de Almeida. (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview. Journal of Inherited Metabolic Disease 29:1, pages 3-20.
Crossref
Nur Aksoy, Mehmet Aksoy, Mahmut Cakmak, Hasan Serdar Gergerlioglu, Vedat Davutoglu, Serdar Soydinc & Iclal Meram. (2006) Increased homocysteine in heart failure: a result of renal impairment?. Clinical Chemistry and Laboratory Medicine (CCLM) 44:11.
Crossref
Bilgin ÖZMEN, Dilek ÖZMEN, Zuhal PARILDAR, Isil MUTAF, Nevbahar TURGAN & Oya BAYINDIR. (2006) Impact of Renal Function or Folate Status on Altered Plasma Homocysteine Levels in Hypothyroidism. Endocrine Journal 53:1, pages 119-124.
Crossref
Mary V. GambleXinhua Liu, Habibul Ahsan, J. Richard PilsnerVesna IlievskiVesna SlavkovichFaruque ParvezDiane Levy, Pam Factor-Litvak & Joseph H. Graziano. (2005) Folate, Homocysteine, and Arsenic Metabolism in Arsenic-Exposed Individuals in Bangladesh. Environmental Health Perspectives 113:12, pages 1683-1688.
Crossref
L. John Hoffer, Orchidee Djahangirian, Paul E. Bourgouin, Johana Eid & Farhad Saboohi. (2005) Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease. Metabolism 54:10, pages 1362-1367.
Crossref
N.R. Robles, J. Romero, L. Gomez Casero, J.M. Escola, J.L. Ramos & E. Sánchez Casado. (2005) Hyperhomocysteinemia in patients with mild chronic renal failure. European Journal of Internal Medicine 16:5, pages 334-338.
Crossref
M.H. Sipahioglu, E. Saglam, O. Oymak, T. Sav, B. Tokgoz, H. Karaca & C. Utas. (2005) Effect of Cyclosporine A on Total Homocysteine Level in a Rabbit Model. Transplantation Proceedings 37:5, pages 2371-2374.
Crossref
S. McDonald, G. Maguire, N. Duarte, X. L. Wang & W. Hoy. (2005) Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community. Internal Medicine Journal 35:5, pages 289-294.
Crossref
Panagiotis T. Vlagopoulos & Mark J. Sarnak. (2005) Traditional and Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease. Medical Clinics of North America 89:3, pages 587-611.
Crossref
Fabiana Baggio Nerbass, Sérgio Antonio Draibe & Lilian Cuppari. (2005) Hiperhomocisteinemia na insuficiência renal crônica. Revista de Nutrição 18:2, pages 239-249.
Crossref
Vandana Menon, Xuelei Wang, Tom Greene, Gerald J. Beck, John W. Kusek, Jacob Selhub, Andrew S. Levey & Mark J. Sarnak. (2005) Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. Kidney International 67:4, pages 1539-1546.
Crossref
José Ignacio Gutiérrez, Flora Pérez, Manuel Tamparillas, José María Grasa, M. Teresa Calvo, Carlos Osuna, Beatriz Sánchez & Manuel Torres. (2005) Polimorfismos en los genes cistationina β-sintasa y metilentetrahidrofolato reductasa como factores de riesgo de enfermedad vascular cerebral. Medicina Clínica 124:8, pages 281-284.
Crossref
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans & D. de Zeeuw. (2005) Biochemical risk markers: a novel area for better prediction of renal risk?. Nephrology Dialysis Transplantation 20:3, pages 497-508.
Crossref
Wolfgang Herrmann & Rima Obeid. (2005) Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients. Clinical Chemistry and Laboratory Medicine (CCLM) 43:10.
Crossref
Olaf Stanger, Martin Weger, Rima Obeid, Werner Temmel, Andreas Meinitzer, Iris Steinbrugger, Otto Schmut & Wolfgang Herrmann. (2005) Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy. Clinical Chemistry and Laboratory Medicine (CCLM) 43:10.
Crossref
Stephen P. McDonald & Wendy E. Hoy. (2005) Interfaces between cardiovascular and kidney disease among Aboriginal Australians. Advances in Chronic Kidney Disease 12:1, pages 39-48.
Crossref
Allon N. Friedman. (2004) High-protein diets: Potential effects on the kidney in renal health and disease. American Journal of Kidney Diseases 44:6, pages 950-962.
Crossref
George Vrentzos, John A. Papadakis, Niki Malliaraki, Evagelos A. Zacharis, Kostas Katsogridakis, Andrew N. Margioris, Panos E. Vardas & Emmanuel S. Ganotakis. (2016) Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort. Angiology 55:5, pages 517-524.
Crossref
Angeles Garcia, Kate Pulman, Katherine Zanibbi, Andrew Day, Linda Galarneau & Morris Freedman. (2004) Cobalamin Reduces Homocysteine in Older Adults on Folic AcidâFortified Diet: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial. Journal of the American Geriatrics Society 52:8, pages 1410-1412.
Crossref
Mildred E. Francis, Paul W. Eggers, Thomas H. Hostetter & Josephine P. Briggs. (2004) Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney International 66:1, pages 303-312.
Crossref
A. Rashed & O. Aboud. (2004) Renal transplantation: Seventeen years of follow-up in Qatar. Transplantation Proceedings 36:6, pages 1835-1838.
Crossref
Michael Y Tsai, Omer Aras, Hakan Sozen, Naomi Q Hanson, Petter S Woll, Valerie L Arends, Donald B Hunninghake & Arthur J Matas. (2004) Plasma homocysteine levels in living kidney donors before and after uninephrectomy. Journal of Laboratory and Clinical Medicine 143:6, pages 340-343.
Crossref
Amir Belson, Jaime Sanchez, Steven R. Alexander, Oscar Salvatierra, Mor H. Dar, Shimon Reif & Peter D. Yorgin. (2004) Hyperhomocysteinemia in pediatric and young adult renal transplant recipients. Pediatric Transplantation 8:2, pages 161-166.
Crossref
G. T. Russo, A. Di Benedetto, C. Giorda, E. Alessi, G. Crisafulli, R. Ientile, E. Di Cesare, P. F. Jacques, G. Raimondo & D. Cucinotta. (2004) Correlates of total homocysteine plasma concentration in type 2 diabetes. European Journal of Clinical Investigation 34:3, pages 197-204.
Crossref
Johannes M M Boots, Maarten H L Christiaans & Johannes P van Hooff. (2004) Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients. Drugs 64:18, pages 2047-2073.
Crossref
Robert W. PowersAlana K. Majors, Laurie J. Kerchner & Kirk P. Conrad. (2016) Renal Handling of Homocysteine During Normal Pregnancy and Preeclampsia. Journal of the Society for Gynecologic Investigation 11:1, pages 45-50.
Crossref
Drukker, Parsons & MaherWalter H. Hörl. 2004. Replacement of Renal Function by Dialysis. Replacement of Renal Function by Dialysis 57 72 .
Simon K AUSTEN, Jeff S COOMBES & Rob G FASSETT. (2003) Homocysteine and cardiovascular disease in renal disease. Review Article. Nephrology 8:6, pages 285-295.
Crossref
Mark J. Sarnak, Andrew S. Levey, Anton C. Schoolwerth, Josef Coresh, Bruce Culleton, L. Lee Hamm, Peter A. McCullough, Bertram L. Kasiske, Ellie Kelepouris, Michael J. Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J. Spinosa & Peter W. Wilson. (2003) Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. Hypertension 42:5, pages 1050-1065.
Crossref
Paul F. Jacques, Gail Rogers, Jose M. Ordovas, Irwin H. Rosenberg, Jacob Selhub, Simonetta Friso, Giuseppina T. Russo, Domenico Cucinotta & Peter W.F. Wilson. (2003) Age and Gender Affect the Relation between Methylenetetrahydrofolate Reductase C677T Genotype and Fasting Plasma Homocysteine Concentrations in the Framingham Offspring Study Cohort. The Journal of Nutrition 133:11, pages 3416-3421.
Crossref
Mark J. Sarnak, Andrew S. Levey, Anton C. Schoolwerth, Josef Coresh, Bruce Culleton, L. Lee Hamm, Peter A. McCullough, Bertram L. Kasiske, Ellie Kelepouris, Michael J. Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J. Spinosa & Peter W. Wilson. (2003) Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. Circulation 108:17, pages 2154-2169.
Crossref
Peter Lind, Bo Hedblad, Björn Hultberg, Lars Stavenow, Lars Janzon & Folke Lindgärde. (2016) Risk of Myocardial Infarction in Relation to Plasma Levels of Homocysteine and Inflammation-Sensitive Proteins: A Long-Term Nested Case-Control Study. Angiology 54:4, pages 401-410.
Crossref
Anja Bosy-Westphal, Martina Ruschmeyer, Norbert Czech, Gerd Oehler, Holger Hinrichsen, Matthias Plauth, Erich Lotterer, Wolfgang Fleig & Manfred James Müller. (2003) Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation,,. The American Journal of Clinical Nutrition 77:5, pages 1269-1277.
Crossref
Robert Clarke, Sarah Lewington & Martin Landray. (2003) Homocysteine, renal function, and risk of cardiovascular disease. Kidney International 63, pages S131-S133.
Crossref
Walter H. Hörl. (2003) Atherosklerose und Urämie: Die Bedeutung nicht-traditioneller RisikofaktorenAtherosclerosis and uremia: The importance of non-traditional risk factors. Wiener Klinische Wochenschrift 115:7-8, pages 220-234.
Crossref
B Hultberg & M Arnadottir. (2003) The effect of cyclosporine on homocysteine export in human cell lines. Transplantation Proceedings 35:2, pages 801-802.
Crossref
Coen van Guldener, Prabath W. B. Nanayakkara & Coen D. A. Stehouwer. (2003) Homocysteine and blood pressure. Current Hypertension Reports 5:1, pages 26-31.
Crossref
Jenq-Wen Huang, Chung-Jen Yen, Mei-Fen Pai, Kwan-Dun Wu, Tun-Jun Tsai & Bor-Shen Hsieh. (2002) Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients. American Journal of Kidney Diseases 40:6, pages 1195-1201.
Crossref
M.Cecilia Courrèges, M.Eugenia Macagno, María L Díaz & Alberto J Monserrat. (2002) Gestational protein restriction induces a reduced number of glomeruli in the young. Nutrition Research 22:12, pages 1497-1505.
Crossref
Cheryl D. BushnellLarry B. Goldstein. (2002) Homocysteine testing in patients with acute ischemic stroke. Neurology 59:10, pages 1541-1546.
Crossref
. (2002) Renovascular Hypertension, Endothelial Function, and Oxidative Stress. New England Journal of Medicine 347:19, pages 1528-1530.
Crossref
H O'Grady, C Kelly, D Bouchier-Hayes & A Leahy. (2002) Homocysteine and occlusive arterial disease. British Journal of Surgery 89:7, pages 838-844.
Crossref
Allon N. Friedman, Lawrence G. Hunsicker, Jacob Selhub & Andrew G. Bostom. (2002) Proteinuria as a Predictor of Total Plasma Homocysteine Levels in Type 2 Diabetic Nephropathy. Diabetes Care 25:11, pages 2037-2041.
Crossref
Majd I. Jaradat & Bruce A. Molitoris. (2002) Cardiovascular Disease in Patients With Chronic Kidney Disease. Seminars in Nephrology 22:6, pages 459-473.
Crossref
Mark J. Sarnak, Shin-Ru Wang, Gerald J. Beck, John W. Kusek, Jacob Selhub, Tom Greene & Andrew S. Levey. (2002) Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases 40:5, pages 932-939.
Crossref
Darren S. Parsons, David A. Reaveley, Darrell V. Pavitt & Edwina A. Brown. (2002) Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment. American Journal of Kidney Diseases 40:5, pages 916-923.
Crossref
Takeshi Nakanishi, Yoshinaga Otaki, Yukiko Hasuike, Masayoshi Nanami, Reiko Itahana, Koji Miyagawa, Hirofumi Nishikage, Masaaki Izumi & Yoshihiro Takamitsu. (2002) Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease. American Journal of Kidney Diseases 40:5, pages 909-915.
Crossref
Michael N Zairis, John A Ambrose, Stavros J Manousakis, Alexander S Stefanidis, Olga A Papadaki, Helen I Bilianou, Mary C DeVoe, Constantine N Fakiolas, Evangelos G Pissimissis, Christopher D Olympios & Stefanos G Foussas. (2002) The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting. Journal of the American College of Cardiology 40:8, pages 1375-1382.
Crossref
Johan L.K. Van Hove, Rita Van Damme‐Lombaerts, Stephanie Grünewald, Heidi Peters, Boudewijn Van Damme, Jean‐Pierre Fryns, Jozef Arnout, Ron Wevers, E. Regula Baumgartner & Brian Fowler. (2002) Cobalamin disorder Cbl‐C presenting with late‐onset thrombotic microangiopathy. American Journal of Medical Genetics 111:2, pages 195-201.
Crossref
. (2002) Strategies to Improve Outcomes after Renal Transplantation. New England Journal of Medicine 346:26, pages 2089-2092.
Crossref
E.O. Uthus, C.D. Davis & K. Yokoi. (2002) Selenium Deficiency in Fisher-344 Rats Decreases Plasma and Tissue Homocysteine Concentrations and Alters Plasma Homocysteine and Cysteine Redox Status. The Journal of Nutrition 132:6, pages 1122-1128.
Crossref
A Merouani, R Rozen, M.-J Clermont & J GenestJrJr. (2002) Renal function, homocysteine, and other plasma thiol concentrations during the postrenal transplant period. Transplantation Proceedings 34:4, pages 1159-1160.
Crossref
Henk J. Blom & S. De Vriese. (2002) Why are homocysteine levels increased in kidney failure? A metabolic approach. Journal of Laboratory and Clinical Medicine 139:5, pages 262-268.
Crossref
Allon N. Friedman, Irwin H. Rosenberg, Jacob Selhub, Andrew S. Levey & Andrew G. Bostom. (2002) Hyperhomocysteinemia in Renal Transplant Recipients. American Journal of Transplantation 2:4, pages 308-313.
Crossref
Yeşim ünlüçerçi, Selda Bekpinar, Figen Gürdöl & Gülay Seferoğlu. (2002) A study on the relationship between homocysteine and diabetic nephropathy in rats. Pharmacological Research 45:3, pages 249-252.
Crossref
Morrell M. Avram. (2002) How Can the Cardiac Death Rate be Reduced in Dialysis Patients?. Seminars in Dialysis 15:1, pages 26-29.
Crossref
Torfi Jonasson, Hans Öhlin, Anders Andersson, Margret Arnadottir & Björn Hultberg. (2002) Renal Function Exerts only a Minor Influence on High Plasma Homocysteine Concentrations in Patients with Acute Coronary Syndromes. Clinical Chemistry and Laboratory Medicine 40:2.
Crossref
Eric C. Seal, Jack Metz, Leon Flicker & Joy Melny. (2002) A Randomized, Double‐Blind, Placebo‐Controlled Study of Oral Vitamin B 12 Supplementation in Older Patients with Subnormal or Borderline Serum Vitamin B 12 Concentrations . Journal of the American Geriatrics Society 50:1, pages 146-151.
Crossref
Marie Chantal Audelin & Jacques GenestJrJr. (2001) Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis 159:2, pages 497-511.
Crossref
Andrew G Bostom, Florian Kronenberg, Paul F Jacques, Erich Kuen, Eberhard Ritz, Paul König, Günther Kraatz, Karl Lhotta, Johannes F.E Mann, Gerhard A Müller, Ulrich Neyer, Werner Riegel, Vedat Schwenger, Peter Riegler & Jacob Selhub. (2001) Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis 159:1, pages 219-223.
Crossref
Linda Davies, Errol G. Wilmshurst, Aidan McElduff, Jenny Gunton, Phillip Clifton-Bligh & Gregory R. Fulcher. (2001) The Relationship Among Homocysteine, Creatinine Clearance, and Albuminuria in Patients With Type 2 Diabetes. Diabetes Care 24:10, pages 1805-1809.
Crossref
ALLON N. FRIEDMAN, ANDREW G. BOSTOM, JACOB SELHUB, ANDREW S. LEVEY & IRWIN H. ROSENBERG. (2001) The Kidney and Homocysteine Metabolism. Journal of the American Society of Nephrology 12:10, pages 2181-2189.
Crossref
Martin J. Landray, Jeetendra Thambyrajah, Fiona J. McGlynn, Heather J. Jones, Colin Baigent, Martin J. Kendall, John N. Townend & David C. Wheeler. (2001) Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. American Journal of Kidney Diseases 38:3, pages 537-546.
Crossref
Gursharan Dogra, Ashley B. Irish & Gerald F. Watts. (2001) Homocysteine and nephrotic syndrome. Nephrology Dialysis Transplantation 16:8, pages 1720-1721.
Crossref
A Passaro. (2001) Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157:1, pages 175-180.
Crossref
Rafael T. Krmar, Jorge R. Ferraris, Jos?? A. Ramirez, Carlos R. Galarza, Gabriel Waisman, Jorge J. Janson, Conrado J. Llapur, Patricia Sorroche, Susana Legal & Mario I. C??mera. (2001) HYPERHOMOCYSTEINEMIA IN STABLE PEDIATRIC, ADOLESCENTS, AND YOUNG ADULT RENAL TRANSPLANT RECIPIENTS. Transplantation 71:12, pages 1748-1751.
Crossref
K. Björkegren & K. Svärdsudd. (2001) Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B12 and folate tissue deficiency markers amongst elderly Swedes – a population‐based study. Journal of Internal Medicine 249:5, pages 423-432.
Crossref
Lingtak-Neander Chan. (2016) Drug-Nutrient Interactions in Transplant Recipients. Journal of Parenteral and Enteral Nutrition 25:3, pages 132-141.
Crossref
Gintaras LiaugaudasPaul F. JacquesJacob SelhubIrwin H. RosenbergAndrew G. Bostom. (2001) Renal Insufficiency, Vitamin B 12 Status, and Population Attributable Risk for Mild Hyperhomocysteinemia Among Coronary Artery Disease Patients in the Era of Folic Acid–Fortified Cereal Grain Flour . Arteriosclerosis, Thrombosis, and Vascular Biology 21:5, pages 849-851.
Crossref
Andrew G Bostom, Florian Kronenberg, Reginald Y Gohh, Vedat Schwenger, Erich Kuen, Paul König, Günther Kraatz, Karl Lhotta, Johannes F.E Mann & Gerhard A Müller. (2001) Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis 156:1, pages 227-230.
Crossref
Jutta Dierkes, Ute Domröse, Klaus Peter Bosselmann, Klaus Hinrich Neumann & Claus Luley. (2001) Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease. Journal of Renal Nutrition 11:2, pages 67-72.
Crossref
Paul F Jacques, Andrew G Bostom, Peter WF Wilson, Sharron Rich, Irwin H Rosenberg & Jacob Selhub. (2001) Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. The American Journal of Clinical Nutrition 73:3, pages 613-621.
Crossref
Andrew G. Bostom, Douglas Shemin, Reginald Y. Gohh, Andrew J. Beaulieu, Pamela Bagley, Ziad A. Massy, Paul F. Jacques, Lance Dworkin & Jacob Selhub. (2001) Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney International 59, pages S246-S252.
Crossref
Cynthia L. Deitrick, Richard E. Katholi, David J. Huddleston, Kathy Hardiek & Lucienne Burrus. (2001) Clinical adaptation of a high-performance liquid chromatographic method for the assay of pyridoxal 5′-phosphate in human plasma. Journal of Chromatography B: Biomedical Sciences and Applications 751:2, pages 383-387.
Crossref
Wolfgang Herrmann, Heike Schorr, Jürgen Geisel & Werner Riegel. (2001) Homocysteine, Cystathionine, Methylmalonic Acid and B-Vitamins in Patients with Renal Disease. Clinical Chemistry and Laboratory Medicine 39:8.
Crossref
Mohamed E. Suliman, Bengt Lindholm, Peter Bárány & Jonas Bergström. (2001) Hyperhomocysteinemia in Chronic Renal Failure Patients: Relation to Nutritional Status and Cardiovascular Disease. Clinical Chemistry and Laboratory Medicine 39:8.
Crossref
Margret Arnadottir, Björn Hultberg & Anna‐Lena Berg. (2001) Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephrophathy. Nephrology Dialysis Transplantation 16:1, pages 45-47.
Crossref
Consuelo Fernández-Miranda, María de la Calle, José Manuel Bris, Mercedes Muelas, Pilar Gómez & Pilar Díaz-Rubio. (2001) Influencia de la menopausia en la concentración plasmática de homocisteína. Medicina Clínica 116:6, pages 206-208.
Crossref
C Gale. (2001) Renal function, plasma homocysteine and carotid atherosclerosis in elderly people. Atherosclerosis 154:1, pages 141-146.
Crossref
Ellen K. Hoogeveen & Kenneth J. Rothman. 2001. Primary and Secondary Preventive Nutrition. Primary and Secondary Preventive Nutrition 127 145 .
W. Herrmann, H. Schorr, M. Bodis, J. P. Knapp, A. Müller, G. Stein & J. Geisel. (2008) Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high‐aged subjects. European Journal of Clinical Investigation 30:12, pages 1083-1089.
Crossref
Nabila Abdella, Olusegun A. Mojiminiyi & Abayomi O. Akanji. (2000) Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease. Diabetes Research and Clinical Practice 50:3, pages 177-185.
Crossref
Ziad A Massy. (2000) Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrology Dialysis Transplantation 15:suppl_5, pages 81-91.
Crossref
David José de Barros Machado, Flávio Jota de Paula, Emil Sabbaga & Luiz Estevan Ianhez. (2000) Hyperhomocyst(e)inemia in chronic stable renal transplant patients. Revista do Hospital das Clínicas 55:5, pages 161-168.
Crossref
Chagriya Kitiyakara, Joyce Gonin, Ziad Massy & Christopher S. Wilcox. (2000) Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia. Current Opinion in Nephrology and Hypertension 9:5, pages 477-487.
Crossref
Lars Brattström & David EL Wilcken. (2000) Homocysteine and cardiovascular disease: cause or effect?. The American Journal of Clinical Nutrition 72:2, pages 315-323.
Crossref
Colin Baigent, Kate Burbury & David Wheeler. (2000) Premature cardiovascular disease in chronic renal failure. The Lancet 356:9224, pages 147-152.
Crossref
Joel G. Ray, David E.C. Cole & Sheila C. Boss. (2000) An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: is a preventable public health issue on the rise?. Clinical Biochemistry 33:5, pages 337-343.
Crossref
Andrew G. Bostom, Douglas Shemin, Reginald Y. Gohh, Andrew J. Beaulieu, Paul F. Jacques, Lance Dworkin & Jacob Selhub. (2000) TREATMENT OF MILD HYPERHOMOCYSTEINEMIA IN RENAL TRANSPLANT RECIPIENTS VERSUS HEMODIALYSIS PATIENTS1. Transplantation 69:10, pages 2128-2131.
Crossref
William G. Christen & Paul M. Ridker. (2000) Blood levels of homocysteine and atherosclerotic vascular disease. Current Atherosclerosis Reports 2:3, pages 194-199.
Crossref
Daniel Weiss. (2000) Hyperhomocysteinemia in Hypothyroidism. Annals of Internal Medicine 132:8, pages 677.
Crossref
Consuelo Fernández‐Miranda, Pilar Gómez, Pilar Díaz‐Rubio, Juana Estenoz, Juan Luis Carrillo, Amado Andrés & José M Morales. (2001) Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clinical Transplantation 14:2, pages 110-114.
Crossref
Amedeo F. De Vecchi, Fabrizia Bamonti–Catena, Silvia Finazzi, Jonica Campolo, Emanuela Taioli, Cristina Novembrino, Patrizia Colucci, Roberto Accinni, Michela De Franceschi, Maria Antonietta Fasano & Anna Teresa Maiolo. (2020) Homocysteine, Vitamin B 12 , and Serum and Erythrocyte Folate in Peritoneal Dialysis and Hemodialysis Patients . Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20:2, pages 169-173.
Crossref
H. Bar‐On, M. Kidron, Y. Friedlander, A. Ben‐Yehuda, J. Selhub, I. H. Rosenberg & G. Friedman. (2001) Plasma total homocysteine levels in subjects with hyperinsulinemia. Journal of Internal Medicine 247:2, pages 287-294.
Crossref
Christopher N Martyn. (2000) Serum homocysteine and risk of coronary heart disease in UK Indian Asians. The Lancet 355:9203, pages 512-513.
Crossref
Per Magne Ueland, Helga Refsum & Jørn Schneede. 2000. Homocysteine and Vascular Disease. Homocysteine and Vascular Disease 59 84 .
O. Nygård, S. E. Vollset, H. Refsum, L. Brattström & P. M. Ueland. (2001) Total homocysteine and cardiovascular disease. Journal of Internal Medicine 246:5, pages 425-454.
Crossref
Jeremy D. KarkJacob SelhubBella AdlerJaime GofinJoseph H. AbramsonGideon FriedmanIrwin H. Rosenberg. (1999) Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem. Annals of Internal Medicine 131:5, pages 321.
Crossref
Andrew G. BostomLinda BaussermanPaul F. JacquesGintaras LiaugaudasJacob SelhubIrwin H. Rosenberg. (1999) Cystatin C as a Determinant of Fasting Plasma Total Homocysteine Levels in Coronary Artery Disease Patients With Normal Serum Creatinine. Arteriosclerosis, Thrombosis, and Vascular Biology 19:9, pages 2241-2244.
Crossref
J.G Ray & C.A Laskin. (1999) Folic Acid and Homocyst(e)ine Metabolic Defects and the Risk of Placental Abruption, Pre-eclampsia and Spontaneous Pregnancy Loss: A Systematic Review. Placenta 20:7, pages 519-529.
Crossref
Sally P. Stabler, Raymond Estacio, Barrett W. Jeffers, Jeffrey A. Cohen, Robert H. Allen & Robert W. Schrier. (1999) Total homocysteine is associated with nephropathy in non—insulin-dependent diabetes mellitus. Metabolism 48:9, pages 1096-1101.
Crossref
ANDREW G. BOSTOM & BRUCE F. CULLETON. (1999) Hyperhomocysteinemia in Chronic Renal Disease. Journal of the American Society of Nephrology 10:4, pages 891-900.
Crossref
Andrew G. Bostom & Bruce Culleton. (1999) Hyperhomocysteinemia in Chronic Renal Disease: Potential Relevance to Arteriosclerosis. Seminars in Dialysis 12:2, pages 103-111.
Crossref
Flemming Wollesen, Lars Brattström, Helga Refsum, Per M. Ueland, Lars Berglund & Christian Berne. (1999) Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney International 55:3, pages 1028-1035.
Crossref
C. Guldener, M. J. F. M. Janssen, K. Meer, A. J. M. Donker & C. D. A. Stehouwer. (2001) Effect of folic acid and betaine on fasting and postmethionine‐loading plasma homocysteine and methionine levels in chronic haemodialysis patients. Journal of Internal Medicine 245:2, pages 175-183.
Crossref
M. René Malinow, Andrew G. Bostom & Ronald M. Krauss. (1999) Homocyst(e)ine, Diet, and Cardiovascular Diseases. Circulation 99:1, pages 178-182.
Crossref
ANDREW G. BOSTOM, REGINALD Y. GOHH, LINDA BAUSSERMAN, DAVID HAKAS, PAUL F. JACQUES, JACOB SELHUB, LANCE DWORKIN & IRWIN H. ROSENBERG. (1999) Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine. Journal of the American Society of Nephrology 10:1, pages 164-166.
Crossref
Coen D.A. Stehouwer, Mari-Anne Gall, Philip Hougaard, Cornelis Jakobs & Hans-Henrik Parving. (1999) Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney International 55:1, pages 308-314.
Crossref
Lars BrattströmDavid E. L. WilckenJohn ÖhrvikLars Brudin. (1998) Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease. Circulation 98:23, pages 2520-2526.
Crossref
Donald G. Weir & John M. Scott. (2007) Homocysteine as a risk factor for cardiovascular and related disease: nutritional implications. Nutrition Research Reviews 11:2, pages 311-338.
Crossref
James D. House, Margaret E. Brosnan & John T. Brosnan. (1998) Renal uptake and excretion of homocysteine in rats with acute hyperhomocysteinemia. Kidney International 54:5, pages 1601-1607.
Crossref
Margret Arnadottir, Björn Hultberg, Jan Wahlberg, Bengt Fellström & Emöke Dimény. (1998) Serum total homocysteine concentration before and after renal transplantation. Kidney International 54:4, pages 1380-1384.
Crossref
Jutta Dierkes, Emmanuel Bissé, Matthias Nauck, Matthias Orth, Horst Mayer, Claus Luley & Heinrich Wieland. (1998) The Diagnostic Value of Serum Homocysteine Concentration as a Risk Factor for Coronary Artery Disease. cclm 36:7, pages 453-457.
Crossref
Coen van Guldener, Ab J.M. Donker, Cornelis Jakobs, Tom Teerlink, Kees de Meer & Coen D.A. Stehouwer. (1998) No net renal extraction of homocysteine in fasting humans. Kidney International 54:1, pages 166-169.
Crossref
Ellen K. Hoogeveen, Pieter J. Kostense, Agnes Jager, Robert J. Heine, Cornelis Jakobs, Lex M. Bouter, Ab J.M. Donker & Coen D.A. Stehouwer. (1998) Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study. Kidney International 54:1, pages 203-209.
Crossref
Florian Kronenberg. (1998) Homocysteine, lipoprotein(a) and fibrinogen. Current Opinion in Nephrology and Hypertension 7:3, pages 271-278.
Crossref
T. Tamura, S.M. Bergman & S.L. Morgan. (2023) Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease. The International Journal of Artificial Organs 21:2, pages 72-74.
Crossref
H. RefsumP. M. UelandO. NygårdS. E. Vollset. (1998) Homocysteine and Cardiovascular Disease. Annual Review of Medicine 49:1, pages 31-62.
Crossref
B.G. Nedrebø, U.-B. Ericsson, O. Nygård, H. Refsum, P.M. Ueland, A. Aakvaag, S. Aanderud & E.A. Lien. (1998) Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 47:1, pages 89-93.
Crossref
Peter Robbins, Mark Forrest & David Royston. (2016) Hypercoagulable States. Seminars in Cardiothoracic and Vascular Anesthesia 1:4, pages 295-318.
Crossref
Andrew G. BostomReginald Y. GohhMichael Y. TsaiBette J. Hopkins-GarciaMarie R. NadeauLisa A. BianchiPaul F. JacquesIrwin H. RosenbergJacob Selhub. (1997) Excess Prevalence of Fasting and Postmethionine-Loading Hyperhomocysteinemia in Stable Renal Transplant Recipients. Arteriosclerosis, Thrombosis, and Vascular Biology 17:10, pages 1894-1900.
Crossref
SP Stabler, J Lindenbaum & RH Allen. (1997) Vitamin B-12 deficiency in the elderly: current dilemmas. The American Journal of Clinical Nutrition 66:4, pages 741-749.
Crossref
Anne B. Guttormsen, Per M. Ueland, Einar Svarstad & Helga Refsum. (1997) Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney International 52:2, pages 495-502.
Crossref
Andrew G. Bostom & Lori Lathrop. (1997) Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney International 52:1, pages 10-20.
Crossref
Bjorn Hultberg, Anders Andersson & Margret Arnadottir. 1997. Homocysteine Metabolism: From Basic Science to Clinical Medicine. Homocysteine Metabolism: From Basic Science to Clinical Medicine 137 143 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.